Patents Assigned to Gelsus Research and Consulting, Inc.
  • Patent number: 7112713
    Abstract: A dressing designed in consideration of Teorell-Meyer gradients is described. This dressing delivers, either individually, or seriatim, pharmaceutically effective amounts of drugs and therapeutic ions to a wound site.
    Type: Grant
    Filed: April 28, 2004
    Date of Patent: September 26, 2006
    Assignee: Gelsus Research and Consulting, Inc.
    Inventor: Nicholas A Sceusa
  • Patent number: 6699282
    Abstract: An implanted device such as a stent is provided which is capable of holding an induced charge or sufficient magnitude that the device may, by electrostatic means, attract the bioactive material to itself. The charge, either positive or negative, or relative to the bioactive material sufficiently positive or negative, is deposited into the implantable device via an exterior induction coil. The implantable device itself becomes an introduced “dosage form”, becoming part of a biologically closed electric circuit, through which the bioactive material is attracted to the implanted device.
    Type: Grant
    Filed: March 6, 2003
    Date of Patent: March 2, 2004
    Assignee: Gelsus Research and Consulting, Inc.
    Inventor: Nicholas A. Sceusa
  • Patent number: 6414033
    Abstract: A method for delivery of pharmaceutically effective amounts of drugs and therapeutic ions is disclosed. More particularly, a method of formulating a dosage form that will move drugs, pro-drugs or therapeutic ions in either cationic or anionic form between voltaic cell compartments of the human body, such as from the mouth into the naso-pharyngeal area or into the lung is set forth. The method utilizes naturally occurring concentration gradients in the form of concentration cells, which are constituents of the anatomy. A dosage formulation designed in consideration of naturally occurring pH gradients, i.e., Teorell-Meyer gradients, and a method of treatment by delivering a pharmaceutically effective amount of ions or drugs using the formulation designed in consideration of Teorell-Meyer gradients, is also described.
    Type: Grant
    Filed: September 20, 1999
    Date of Patent: July 2, 2002
    Assignee: Gelsus Research and Consulting, Inc.
    Inventor: Nicholas Sceusa